These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 7731508
21. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H. J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412 [Abstract] [Full Text] [Related]
24. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y. Oral Oncol; 2004 May 11; 40(5):474-82. PubMed ID: 15006618 [Abstract] [Full Text] [Related]
25. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors. Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S. Cancer Res; 2004 Sep 01; 64(17):6287-95. PubMed ID: 15342417 [Abstract] [Full Text] [Related]
29. A new boronated porphyrin (STA-BX909) for neutron capture therapy: an in vitro survival assay and in vivo tissue uptake study. Matsumura A, Shibata Y, Yamamoto T, Yoshida F, Isobe T, Nakai K, Hayakawa Y, Kiriya M, Shimojo N, Ono K, Sakata I, Nakajima S, Okumura M, Nose T. Cancer Lett; 1999 Jul 01; 141(1-2):203-9. PubMed ID: 10454263 [Abstract] [Full Text] [Related]
30. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA. Chou FI, Chung HP, Liu HM, Chi CW, Lui WY. Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S105-8. PubMed ID: 19375330 [Abstract] [Full Text] [Related]
31. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine. Wittig A, Huiskamp R, Moss RL, Bet P, Kriegeskotte C, Scherag A, Hilken G, Sauerwein WA. Radiat Res; 2009 Oct 01; 172(4):493-9. PubMed ID: 19772470 [Abstract] [Full Text] [Related]
32. Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial. Hideghéty K, Sauerwein W, Wittig A, Götz C, Paquis P, Grochulla F, Haselsberger K, Wolbers J, Moss R, Huiskamp R, Fankhauser H, de Vries M, Gabel D. J Neurooncol; 2003 Oct 01; 62(1-2):145-56. PubMed ID: 12749710 [Abstract] [Full Text] [Related]
33. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Ichikawa H, Taniguchi E, Fujimoto T, Fukumori Y. Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S111-4. PubMed ID: 19376721 [Abstract] [Full Text] [Related]
39. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model. Ozawa T, Afzal J, Lamborn KR, Bollen AW, Bauer WF, Koo MS, Kahl SB, Deen DF. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):247-52. PubMed ID: 16111595 [Abstract] [Full Text] [Related]
40. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model. Suzuki M, Masunaga S, Kinashi Y, Nagata K, Sakurai Y, Nakamatsu K, Nishimura Y, Maruhashi A, Ono K. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):260-6. PubMed ID: 15093923 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]